Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles
Linlin Yang(City Of Hope National Medical Center), Terence M. Williams(City Of Hope National Medical Center)
Cited by 24
Related Papers
Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair
|Nucleic Acids Research|2021|68
TRPS1 regulates the opposite effect of progesterone via RANKL in endometrial carcinoma and breast carcinoma
|Cell Death Discovery|2023|7
Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach
|ACS Omega|2023|7
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect
|Frontiers in Immunology|2024|7
JNTX-101, a novel albumin-encapsulated gemcitabine prodrug, is efficacious and operates via caveolin-1-mediated endocytosis
|Molecular Therapy — Oncolytics|2023|6